$TOST Balance Sheet | Understand Stock

$TOST

$32.13 -$0.58 (1.77%) Close

$TOST Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets:
Current assets:
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Merchant cash advances and loans receivable, net of allowance for uncollectible loans of $3,668 and $4,454, respectively, at September 30, 2021 and December 31, 2020
Inventories, net
Deferred costs, net
Prepaid expenses and other current assets
Other current assets
Total current assets
Property, equipment and right-of-use assets, net
Operating lease right-of-use assets
Intangible assets, net
Goodwill
Restricted cash
Deferred Costs, Noncurrent
Security deposits
Deferred costs, non-current
Other non-current assets
Total non-current assets
Total assets

Liabilities and Stockholders’ Equity:
Current liabilities:
Accounts payable
Operating lease liabilities
Deferred revenue
Accrued expenses and other current liabilities
Total current liabilities
Long-term debt
Derivative liabilities
Warrants to purchase common stock
Preferred Stock Warrants
Common Stock Warrants
Total warrants to purchase common stock

Operating lease liabilities, non-current
Deferred rent, non-current
Deferred revenue, non-current
Other long-term liabilities
Total long-term liabilities
Total liabilities
Convertible preferred stock, $0.000001 par value—no shares authorized, issued or outstanding as of September 30, 2021; 257,245,680 authorized and 253,832,025 shares issued and outstanding at December 31, 2020; total liquidation value of $849,970 at December 31, 2020.
Stockholders’ Equity:
Preferred stock, par value $0.000001 per share; 100 million shares authorized; no shares issued or outstanding
Common stock, par value $0.000001 per share: Class A - 7,000 million shares authorized; 512 million and 523 million shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Class B - 700 million shares authorized; 65 million and 66 million shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common Class A
Common Class B
Total common stock, par value $0.000001 per share: Class A - 7,000 million shares authorized; 512 million and 523 million shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Class B - 700 million shares authorized; 65 million and 66 million shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Treasury stock, at cost - no and 0 shares outstanding as of December 31, 2023 and 2022, respectively
Accumulated other comprehensive income (loss)
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Common stock, issued (in shares)
Common Class A
Common Class B
Total common stock, issued (in shares)

Common stock, outstanding (in shares)
Common Class A
Common Class B
Total common stock, outstanding (in shares)

Comments